While we have demonstrated that either epithelial or systemic TGFβ signaling deficiency accelerates intestinal tumorigenesis in an inherited model of mutant APCΔ468, global APC mutations are representative of a small subgroup of cancer patients, the overwhelming majority of which present with sporadic APC mutations [17]. The gene discussed is APC; the disease is cancer.